For nearly a decade, researchers and scientists have been relying on the ALS Therapy Alliance's expertise and funding to advance their studies of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

The organization has raised more than $11 million, and 100 percent of those proceeds have been used to further ALS research. The ALS Therapy Alliance, its funding and supported research are overseen by the group's elite board of award-winning researchers and scientists, as well as corporate executives and individuals who strive to learn more about the neurodegenerative disease, its cause and possible cure.